The National Reining Horse Association (NRHA) has joined with Boehringer Ingelheim in a corporate partnership. NRHA is a worldwide organization dedicated to the promotion of the reining horse and the sport of Reining. Boehringer Ingelheim is a global leader in animal health, supplying innovative vaccine and pharmaceutical products to help improve the quality of life for animals.
A healthy commitment to the reining horse
The National Reining Horse Association, a worldwide promoter of the reining horse, and Boehringer Ingelheim, a global leader in animal health, have joined forces in a corporate partnership.
© 2013 by Allx
Todd Barden, NRHA’s Sr. Director of Sponsorship & Television Programming, says, “NRHA is honored to have Boehringer Ingelheim become an active presence as an NRHA Corporate Partner. Their vast selection of USDA and FDA-approved equine products will be a great benefit to NRHA members and their horses. We look forward to working with our new partners to showcase their products to the world of Reining.”
Boehringer Ingelheim Vetmedica, Inc. (BIVI) ranks among the top animal health companies in the U.S. BIVI is a leading supplier of animal health products for livestock, companion animals and equine. Headquartered in St. Joseph, Mo., the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for veterinary medicine.
“We are excited to be a corporate partner of NRHA,” says Marion Tittle, Associate Director, Equine Marketing. “With the high level of competition involved with NRHA events, we know that keeping a reining horse healthy is vital to their performance and overall well-being.”
Boehringer Ingelheim Vetmedica, Inc. (BIVI) is the manufacturer of the leading pharmaceutical product SURPASS®. Surpass (1% diclofenac sodium) is a trusted name in effective control of joint pain and inflammation associated with osteoarthritis in horses. Using patented WISDOM® delivery technology, SURPASS® enhances absorption into the area of inflammation. SURPASS® is an FDA-approved product which demonstrates it is safe, effective and manufactured with high-quality standards.
In addition to SURPASS, BIVI also manufactures Ventipulmin® (clenbuterol hydrochloride), which is the only FDA-approved clenbuterol for managing both inflammatory airway disease (IAD) and recurrent airway obstruction (RAO), two non-infectious airway diseases similar to asthma in humans that can debilitate the horse. VENTIPULMIN helps smooth airway muscles to relax relieving bronchospasms resulting in bronchodilation and helping the horse breathe easier.
Along with leading pharmaceuticals, BIVI also produces the Vetera® vaccine line. VETERA vaccines offer the convenience of VETERA Gold, which protects horses against seven diseases in one vaccine, but also offers a customizable approach. With more than eight additional vaccine combinations, the full Vetera line provides horses with maximum protection that can be tailored to meet their specific needs.
For more information about BIVI’s equine product line
SURPASS Important Safety Information: Like any medication, non-steroidal anti-inflammatory drugs (NSAIDs) such as SURPASS may cause side effects. These are usually mild and affect primarily the gastrointestinal system, but more serious side effects can occur. NSAIDs should only be administered under the direction of a licensed professional.
SURPASS topical cream is only approved for use in horses and has not been evaluated in breeding, pregnant, or lactating horses, or in horses under 1 year of age. Do not exceed the recommended dose. Wear gloves when administering SURPASS. If direct contact with skin occurs, wash immediately with soap and water. Please refer to the package insert for complete product information.
Ventipulmin Syrup should not be used in pregnant mares near term. Because tachycardia may occur, Ventipulmin Syrup should not be used in horses suspected of having cardiovascular impairment. Treatment starting with doses higher than the initial dose is not recommended. Mild sweating, muscle tremor, restlessness, urticaria and tachycardia may be observed in some horses during the first few days of treatment.
Incorporated in 1966, the National Reining Horse Association is the standard-setting body for the sport of Reining. NRHA, with their International Headquarters in Oklahoma City, is responsible for promoting the sport of Reining and working to ensure the highest standards of competition. To learn more about the NRHA, its programs and family of corporate partners, visit nrha.com.
By Christina Brezack